Biotech - Press Releases

Date	Title	Company
17-Oct-2023	Fighting Counterfeiting in the Medical and Pharmaceutical Industry: Origify offers End-to-End Authentication	Bosch
17-Oct-2023	PureTech to Present at Two Upcoming Investor Conferences	PureTech Health
17-Oct-2023	SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease	SpliceBio
17-Oct-2023	Tessellate BIO Emerges from Stealth The Next Generation Synthetic Lethality Precision Oncology Company	Tessellate BIO
17-Oct-2023	Lytix Biopharma granted up to NOK14.3m (US$1.3m) of public non-dilutive funding from ’SkatteFUNN’	Lytix Biopharma
17-Oct-2023	STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	STORM Therapeutics Ltd
17-Oct-2023	Myricx Bio to Present Preclinical Data Validating NMTi as a Novel ADC Payload Class	Myricx Bio
17-Oct-2023	Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam	Abcam plc
17-Oct-2023	PATIENTS DOSED WITH METHYLONE IN LONDON IN NEW CLINICAL TRIAL TO TREAT PTSD	Clerkenwell Health
17-Oct-2023	Cherwell to participate in sterile product manufacturing think tank discussions	Cherwell
17-Oct-2023	Bloomsbury Genetic Therapies Receives Orphan Drug Designations from the European Commission and the US FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C and Provides Update on Type B Pre-IND Interaction with the US FDA	Bloomsbury Genetic Therapies Limited
17-Oct-2023	AI startup Leucine nets $7M to level up Pharma manufacturing compliance to keep pace with drug innovation	Leucine nets $7M to level up pharma manufacturing compliance to keep pace with drug innovation
17-Oct-2023	Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment	Tilray Medical
17-Oct-2023	Lytix Biopharma’s abstract with preliminary data from the ATLAS-IT-05 study is published.	Lytix Biopharma
17-Oct-2023	SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline	Synaffix B.V.
17-Oct-2023	Myricx Bio to Present Preclinical Data Validating NMTi as a Novel ADC Payload Class	Myricx Bio
17-Oct-2023	Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox	Amerigo Scientific
17-Oct-2023	Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research	Protheragen
17-Oct-2023	CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research	CD Genomics
17-Oct-2023	CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology	CD Genomics